Every growing company will, at some point, need to convince people to invest or continue investing in the business.

But what motivates investors in their decision-making process? And does addressing potential objections upfront impact their decisions?

To find out, Dr. Carmen Simon, cognitive neuroscientist and Chief Science Officer at Corporate Visions and Emblaze (formerly B2B DecisionLabs), led a neuroscience study to see how investors and analysts react to risk-related information in a first-call presentation.

Get this research brief to find out:

• How including potential objections in a slide impacts attention, satisfaction with the investment opportunity, and the motivation to act.
• How introducing risk-related information impacts how investors remember important points from the presentation.
• Whether you should share risk-related information during a first-call investor presentation.